Gene and cell therapy is moving fast – and in a clear direction. Programs are pushing toward more complex payloads, virus-free engineering, and manufacturing models that can scale from early research ...

VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, is the first to demonstrate the isolation and analysis of >99% pure circulating tumor-derived DNA (ctDNA).

Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the future of gene editing.

Generalist Biological AI Models Decode the Language of Life Biology has always been an information science at heart. DNA stores ...

Targets $36 Billion TAM in Early Cancer Detection and MRD. Company in active discussions with global diagnostic leaders to accelerate commercialization. HENDERSON, Nev., March 18, ...

A protein long studied for its role in amyotrophic lateral sclerosis and frontotemporal dementia now appears to serve a second, equally critical function, safeguarding the integrity of human DNA.

Nvidia CEO Jensen Huang unveiled the Groq 3 Language Processing Unit (LPU), marking the first chip release from the AI startup Nvidia largely acquired in a $20 billion asset deal last December, its ...

Four-way collaboration brings together world-leading AI and biological expertise to make AI-predicted protein complex structures openly available to ...

What China’s experience shows is that the real value of AI lies not in the technology itself, but in its application. The companies that are moving ahead are those embedding AI into products, ...

Head and neck cancer (HNC) represents a significant global health challenge, characterized by aggressive local invasion, frequent recurrence, and poor survival rates. Beyond its physical burden, HNC ...